Clinverse Names New CEO

Denis Connaghan has been appointed chief executive officer of Clinverse, Inc. Mr. Connaghan brings more than 25 years of commercialization experience across multiple industries, including technology, healthcare, insurance, life sciences and IT.
 
Prior to joining the company, Mr. Connaghan served as a management consultant and held interim executive roles at GMA Healthcare, Infina Connect and several other life science IT and services companies. He also served as the chief executive officer of etrials Worldwide, an eclinical solutions provider, prior to its acquisition by Merge Healthcare.
 
“I’m thrilled to join such a fast-paced, growing company,” said Mr. Connaghan. “Clinverse’s FLS platform is an industry-first and continues to outpace the industry in terms of innovation. We are well positioned to build on this solid technology foundation, and I look forward to working with the Clinverse team to capitalize on my global and industry expertise to drive additional opportunities in the clinical trial services market.”
 
Also, Tim Immel, founder and former chief executive officer of Clinverse, will take on the role of chief product officer, where he will pursue product development and ensure the company maintains and grows its financial lifecycle systems for clinical trials.
 
“Of all the many responsibilities I have had at Clinverse, none has been more important to the business or more gratifying to me personally than to design and build the exceptional products and services that we offer, products that fill an important yet unmet need in the marketplace,” said Mr. Immel. “Denis’s leadership is critical to our long-term success as we continue taking Clinverse to the heights we all envision, while delivering the highest quality service to clients.”